Cargando…
Improving the Safety of High-Flow Therapies in the Management of Patients With COVID-19
Autores principales: | Madney, Yasmin M., Esquinas, Antonio M., Saeed, Haitham, Harb, Hadeer S., Abdelrahim, Mohamed E.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533713/ https://www.ncbi.nlm.nih.gov/pubmed/33036099 http://dx.doi.org/10.1016/j.chest.2020.06.040 |
Ejemplares similares
-
Noninvasive ventilation usage time and survival rate in patients with acute respiratory failure: some key insights
por: Madney, Yasmin M., et al.
Publicado: (2020) -
Vitamins and other immune-supportive elements as cofactors for passing the COVID-19 pandemic
por: Saeed, Haitham, et al.
Publicado: (2021) -
Aerosol delivery aspects within a high-flow therapy system in COPD patients
por: Madney, Yasmin M., et al.
Publicado: (2021) -
Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality
por: Osama El-Gendy, Ahmed, et al.
Publicado: (2020) -
Success or Failure of High-Flow Nasal Oxygen Therapy: The ROX Index Is Good, but a Modified ROX Index May Be Better
por: Karim, Habib M. R., et al.
Publicado: (2019)